Author: Craig Boerner
Sep. 19, 2019—A single pill containing low doses of three medications to treat high blood pressure and one to lower cholesterol reduced the estimated risk of cardiovascular disease by 25%, according to a VUMC study.
Jun. 9, 2019—Drug delays onset of type 1 diabetes by two years
Jun. 7, 2019—VUMC's Dmochowski Receives AUA’s Victor A. Politano Award
May. 3, 2019—A roadmap to create an implantable dialysis system that would allow patients to treat kidney failure at home has won researchers from Vanderbilt University Medical Center (VUMC), UC San Francisco (UCSF), and Silicon Kidney one of 15 cash prizes in the inaugural KidneyX’s Redesign Dialysis Phase I competition.
Apr. 4, 2019—Joseph “Jay” Smith Jr., MD, professor of Urologic Surgery, has been awarded the 2019 Willet F. Whitmore Jr. Award and Lectureship from the Society of Urologic Oncology (SUO).
Mar. 28, 2019—Prostate cancer patients in Nashville and Los Angeles are benefiting from a computer-based decision aid that implements the latest study results to tailor treatment options to an individual’s quality-of-life priorities.
Feb. 18, 2019—Thousands of Americans die each year during a dangerous two-minute procedure to insert a breathing tube. Now a Vanderbilt University Medical Center (VUMC) study in the New England Journal of Medicine (NEJM) is showing that using bag-mask ventilation, squeezing air from a bag into the mouth for 60 seconds to help patients’ breathing, improves outcomes and could potentially save lives.
Jan. 31, 2019—Daniel Barocas, MD, MPH, associate professor of Urology, is being recognized with a national award from the Society of Urologic Oncology (SUO) for his efforts to develop urologic cancer quality measures.
Jan. 28, 2019—Vanderbilt vaccine researchers are enrolling adult volunteers in a National Institutes of Health (NIH)-sponsored Phase II clinical trial that will study a next generation pertussis vaccine that may protect people from whooping cough.
Dec. 13, 2018—Vanderbilt urologic surgeons are offering an alternative therapy for prostate cancer patients considered to be low-to-intermediate risk, a middle ground between active surveillance and aggressive therapy.
Dec. 12, 2018—Children and young adults without psychosis who are prescribed high-dose antipsychotic medications are at increased risk of unexpected death, despite the availability of other medications to treat their conditions, according to a Vanderbilt University Medical Center study published today in JAMA Psychiatry. Unexpected death includes deaths due to unintentional drug overdose or cardiovascular/metabolic causes.